LYRA - Lyra Therapeutics, Inc.

Name: Lyra Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

LYRA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Palasis Maria	1.10M	$3.69M	-
CFO	Cavalier Jason	518.5K	$1.74M	-
10%	Perceptive Advisors LLC	14.0K	$54.7K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 6, 2026	Cavalier Jason	Chief Financial Officer	Sell10b5-1	769	$3.36	$2,586.92	-0.1%	-85.4%	-
Jan 6, 2026	Palasis Maria85	President &CEO	Sell10b5-1	1,702	$3.36	$5,725.53	-0.2%	-85.4%	-
Nov 13, 2025	Perceptive Advisors LLC51	10% Owner	Sell	45,875	$3.98	$182,515.31	-76.6%	-64.1%	-
Nov 10, 2025	Perceptive Advisors LLC51	10% Owner	Sell	70,390	$4.89	$344,219.10	-79.0%	-65.5%	-
Jul 10, 2025	Palasis Maria85	President &CEO	Sell10b5-1	1,565	$8.91	$13,944.15	-0.1%	-14.8%	-94.0%
Jul 10, 2025	Cavalier Jason	Chief Financial Officer	Sell10b5-1	684	$8.91	$6,094.44	-0.1%	-14.8%	-94.0%
Nov 10, 2023	Waksal Harlan	Executive Chair	Buy	25,000	$2.96	$74,095.00	+10.6%	+60.3%	-91.1%
May 31, 2023	Anderson Edward T	Director, 10% Owner	Buy	1,805,416	$2.43	$4,387,160.88	+252.0%	+32.7%	-87.1%
May 31, 2023	Nbvm Gp, LLC	10% Owner	Buy	1,805,416	$2.43	$4,387,160.88	+252.0%	+32.7%	-87.1%
May 31, 2023	Perceptive Advisors LLC51	Director, 10% Owner	Buy	3,610,832	$2.49	$8,999,998.76	+45.9%	+32.7%	-87.1%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC